Literature DB >> 6622210

Enzymatic O-methylation of the dopamine agonist dipropyl-5,6-dihydroxyaminotetralin: isolation and structure elucidation of the O-methylated metabolite.

H Rollema, C J Grol.   

Abstract

The (+)-enantiomer of the potent dopamine agonist dipropyl-5,6-dihydroxyaminotetralin (DP-5,6-diOH-ATN) is metabolized in vitro by catechol-O-methyltransferase (COMT) to one O-methyl derivative. This compound was isolated from the incubation mixture by reversed-phase HPLC, after the incubation mixture had been purified over Sephadex G 10 columns and the excess parent catecholamine had been removed with alumina. One of the possible O-methyl metabolites, dipropyl-5-hydroxy-6-methoxyaminotetralin, was synthesized from dipropyl-5,6-dimethoxyaminotetralin by a regioselective mono-demethylation with iodotrimethylsilane. Comparison of chromatographic and spectral data of the products from incubation and synthesis showed that different isomers are formed; i,e. DP-5,6-diOH-ATN is exclusively meta-O-methylated by COMT in vitro to dipropyl-5-methoxy-6-hydroxyaminotetralin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6622210     DOI: 10.1007/bf01961474

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  7 in total

1.  Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonists.

Authors:  J D McDermed; G M McKenzie; A P Phillips
Journal:  J Med Chem       Date:  1975-04       Impact factor: 7.446

2.  Facile syntheses of potent dopaminergic argonists and their effect on neurotransmitter release.

Authors:  A S Horn; C J Grol; D Dijkstra; A H Mulder
Journal:  J Med Chem       Date:  1978-08       Impact factor: 7.446

3.  Regioselective O-demethylation in the aporphine alkaloid series.

Authors:  R Ahmad; J M Saá; M P Cava
Journal:  J Org Chem       Date:  1977-04-01       Impact factor: 4.354

4.  Determination of picomole amounts of dopamine, noradrenaline, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid in nervous tissue after one-step purification on Sephadex G-10, using high-performance liquid chromatography with a novel type of electrochemical detection.

Authors:  B H Westerink; T B Mulder
Journal:  J Neurochem       Date:  1981-04       Impact factor: 5.372

5.  Reversed-phase liquid chromatography with amperometric detection of lipophilic dopamine analogues and determination of brain and serum concentrations after sample clean-up on small sephadex G-10 columns.

Authors:  M G Feenstra; J W Homan; D Dijkstra; T B Mulder; H Rollema; B H Westerink; A S Horn
Journal:  J Chromatogr       Date:  1982-07-09

6.  The significance of COMT activity in controlling dopamine agonist levels in brain and serum: studies with a prodrug and a metabolite of 6,7-ADTN.

Authors:  H Rollema; B H Westerink; T B Mulder; D Dijkstra; M G Feenstra; A S Horn
Journal:  Eur J Pharmacol       Date:  1980-06-27       Impact factor: 4.432

7.  In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTN.

Authors:  M G Feenstra; H Rollema; T B Mulder; B H Westerink; A S Horn
Journal:  Life Sci       Date:  1983-03-21       Impact factor: 5.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.